Mate you bid, why, cause you liked it.
then when you found out you got nothing you say “For what it's worth - I'm not going anywhere near this now. It seems way too hyped for my liking, particularly given its only very early into phase 1 trials (yes I know some companies have been bought in early stage phase 1 or even pre-clinical).”
if that ain’t sour grapes what is?
